| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.93▲ | 0.89▲ | 0.88▲ | 0.83▲ | 0.84▲ |
| MA10 | 0.90▲ | 0.87▲ | 0.98▼ | 0.78▲ | 0.90▲ |
| MA20 | 0.88▲ | 0.97▼ | 0.88▲ | 0.82▲ | 1.07▼ |
| MA50 | 0.92▲ | 0.83▲ | 0.79▲ | 0.91▲ | N/A |
| MA100 | 1.00▼ | 0.82▲ | 0.83▲ | 1.10▼ | N/A |
| MA200 | 0.88▲ | 0.87▲ | 0.90▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | -0.015▼ | -0.011▼ | 0.025▲ | N/A |
| RSI | 63.499▲ | 53.752▲ | 56.067▲ | 56.576▲ | 38.889▼ |
| STOCH | 97.824▲ | 38.961 | 25.019 | 36.731 | 16.962▼ |
| WILL %R | -8.534▲ | -61.287 | -65.305 | -58.381 | -62.436 |
| CCI | 105.225▲ | 1.187 | -21.289 | 112.053▲ | -0.661 |
|
Tuesday, September 22, 2026 06:46 AM
Filana Therapeutics shares rose after the FDA lifted a clinical hold on simufilam, allowing an epilepsy study to proceed.
|
|
Tuesday, September 22, 2026 01:00 AM
Patient screening for the Phase 2a study is expected to begin by the first quarter of 2027Filana has engaged a leading clinical research organization, has identified clinical trial sites, and is ...
|
|
Sunday, September 20, 2026 06:46 PM
Filana Therapeutics, Inc., formerly Cassava Sciences, Inc., is a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous s ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/26 | 0.9956 | 0.9956 | 0.8041 | 0.9322 | 4,278,953 |
| 22/09/26 | 0.9848 | 1.30 | 0.9011 | 1.03 | 93,522,837 |
| 21/09/26 | 0.735 | 0.767 | 0.7288 | 0.7395 | 336,345 |
| 18/09/26 | 0.72 | 0.73 | 0.71 | 0.73 | 122,800 |
| 17/09/26 | 0.685 | 0.7245 | 0.6813 | 0.72 | 273,234 |
| 16/09/26 | 0.69 | 0.70 | 0.67 | 0.68 | 379,600 |
| 15/09/26 | 0.7277 | 0.7277 | 0.68 | 0.6965 | 445,926 |
| 14/09/26 | 0.7698 | 0.77 | 0.7145 | 0.7188 | 378,661 |
| 11/09/26 | 0.81 | 0.81 | 0.7661 | 0.7726 | 309,518 |
| 10/09/26 | 0.7993 | 0.81 | 0.7722 | 0.8089 | 303,316 |
|
|
||||
|
|
||||
|
|